Supplementary Data from Preclinical Characterization of HPN536, a Trispecific, T-Cell–Activating Protein Construct for the Treatment of Mesothelin-Expressing Solid Tumors
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)